MedSmart Group (MSGP) Ratios

11 Followers

MedSmart Group Ratios

MSGP's free cash flow for Q3 2022 was $0.00. For the 2022 fiscal year, MSGP's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.

Ratios	TTM	Dec 20	Dec 19	Dec 18
Liquidity Ratios
Current Ratio	0.28	0.28	<0.01	0.03
Quick Ratio	0.28	0.28	<0.01	0.02
Cash Ratio	0.28	0.28	<0.01	0.02
Solvency Ratio	-0.06	-0.06	0.13	4.56
Operating Cash Flow Ratio	-0.10	-0.68	-0.02	1.35
Short-Term Operating Cash Flow Coverage	-0.14	-0.99	-0.09	4.41
Net Current Asset Value	$ -799.05K	$ -799.05K	$ -392.33K	$ -285.03K
Leverage Ratios
Debt-to-Assets Ratio	1.05	1.05	31.93	10.35
Debt-to-Equity Ratio	-4.48	-4.48	-0.18	-0.32
Debt-to-Capital Ratio	1.29	1.29	-0.22	-0.46
Long-Term Debt-to-Capital Ratio	-0.40	-0.40	0.00	0.00
Financial Leverage Ratio	-4.28	-4.28	>-0.01	-0.03
Debt Service Coverage Ratio	0.16	-0.10	0.81	2.28
Interest Coverage Ratio	-0.67	-9.54	-1.94	0.00
Debt to Market Cap	11.61	1.98	0.11	0.12
Interest Debt Per Share	0.02	0.88	0.09	0.06
Net Debt to EBITDA	13.80	-19.17	0.79	0.41
Profitability Margins
Gross Profit Margin	0.00%	0.00%	22.24%	28.16%
EBIT Margin	0.00%	0.00%	-1.90%	25.29%
EBITDA Margin	0.00%	0.00%	1.99%	3.87%
Operating Profit Margin	0.00%	0.00%	-1.69%	3.87%
Pretax Profit Margin	0.00%	0.00%	-2.77%	25.29%
Net Profit Margin	0.00%	0.00%	-2.77%	25.29%
Continuous Operations Profit Margin	0.00%	0.00%	-2.77%	25.29%
Net Income Per EBT	79.00%	100.00%	100.00%	100.00%
EBT Per EBIT	114.19%	33.39%	164.09%	653.55%
Return on Assets (ROA)	-10.14%	-7.55%	-5565.69%	15394.34%
Return on Equity (ROE)	26.84%	32.28%	31.10%	-469.78%
Return on Capital Employed (ROCE)	-28.11%	-56.55%	18.95%	-71.88%
Return on Invested Capital (ROIC)	-10.91%	-27.77%	23.07%	-105.05%
Return on Tangible Assets	-10.14%	-7.55%	-5565.69%	15394.34%
Earnings Yield	-244.77%	-31.12%	-19.52%	183.05%
Efficiency Ratios
Receivables Turnover	0.00	0.00	0.00	0.00
Payables Turnover	2.17	0.52	27.17	126.80
Inventory Turnover	0.00	0.00	0.00	1.88K
Fixed Asset Turnover	0.00	0.00	0.00	0.00
Asset Turnover	0.00	0.00	2.01K	608.76
Working Capital Turnover Ratio	0.00	0.00	-13.02	-5.50
Cash Conversion Cycle	-168.12	-703.76	-13.44	-2.68
Days of Sales Outstanding	0.00	0.00	0.00	0.00
Days of Inventory Outstanding	0.00	0.00	0.00	0.19
Days of Payables Outstanding	168.12	703.76	13.44	2.88
Operating Cycle	0.00	0.00	0.00	0.19
Cash Flow Ratios
Operating Cash Flow Per Share	>-0.01	-0.34	>-0.01	0.27
Free Cash Flow Per Share	>-0.01	-0.40	>-0.01	0.27
CapEx Per Share	<0.01	0.06	0.00	0.00
Free Cash Flow to Operating Cash Flow	1.00	1.18	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	-10.82K	-5.67	0.00	0.00
Capital Expenditure Coverage Ratio	-10.82K	-5.67	0.00	0.00
Operating Cash Flow Coverage Ratio	-0.05	-0.39	-0.09	4.41
Operating Cash Flow to Sales Ratio	0.00	0.00	>-0.01	0.07
Free Cash Flow Yield	-139.02%	-198.31%	-1.04%	54.23%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-0.41	-3.21	-5.12	0.55
Price-to-Sales (P/S) Ratio	0.00	0.00	0.14	0.14
Price-to-Book (P/B) Ratio	-0.18	-1.04	-1.59	-2.57
Price-to-Free Cash Flow (P/FCF) Ratio	-0.72	-0.50	-96.02	1.84
Price-to-Operating Cash Flow Ratio	-0.72	-0.59	-96.02	1.84
Price-to-Earnings Growth (PEG) Ratio	<0.01	0.09	0.05	<0.01
Price-to-Fair Value	-0.18	-1.04	-1.59	-2.57
Enterprise Value Multiple	14.45	-24.47	7.90	3.98
Enterprise Value	690.71K	841.95K	694.83K	814.82K
EV to EBITDA	14.45	-24.47	7.90	3.98
EV to Sales	0.00	0.00	0.16	0.15
EV to Free Cash Flow	-15.95	-2.33	-106.75	2.05
EV to Operating Cash Flow	-15.95	-2.74	-106.75	2.05
Tangible Book Value Per Share	>-0.01	-0.19	-0.31	-0.19
Shareholders’ Equity Per Share	>-0.01	-0.19	-0.31	-0.19
Tax and Other Ratios
Effective Tax Rate	0.21	0.00	0.00	0.00
Revenue Per Share	0.00	0.00	3.53	3.62
Net Income Per Share	>-0.01	-0.06	-0.10	0.92
Tax Burden	0.79	1.00	1.00	1.00
Interest Burden	-3.35	1.46	1.45	1.00
Research & Development to Revenue	0.00	0.00	0.00	0.00
SG&A to Revenue	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00
Income Quality	0.57	5.42	0.05	0.30

Currency in USD